(Q40511274)

21 September 2017

title

Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12. (English)

1 reference

21 September 2017

1 reference

Homma S

1

1 reference

21 September 2017

Kikuchi T

2

1 reference

21 September 2017

Ishiji N

3

1 reference

21 September 2017

Ochiai K

4

1 reference

21 September 2017

Takeyama H

5

1 reference

21 September 2017

Saotome H

6

1 reference

21 September 2017

Sagawa Y

7

1 reference

21 September 2017

Hara E

8

1 reference

21 September 2017

Kufe D

9

1 reference

21 September 2017

Ryan JL

10

1 reference

21 September 2017

Ohno T

11

1 reference

21 September 2017

Toda G

12

1 reference

21 September 2017

publication date

1 April 2005

1 reference

European Journal of Clinical Investigation

21 September 2017

published in

1 reference

21 September 2017

volume

35

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

279-286

1 reference

Cancer vaccines based on the identification of genes encoding cancer regression antigens

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Dendritic cells presenting tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Dendritic cells as adjuvants for immune-mediated resistance to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

Hybrid cell vaccination in metastatic melanoma: clinical and immunologic results of a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01494.X

10.1111/J.1365-2362.2005.01494.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference